Skip to content

To study the oxidant-antioxidant status in vitiligo patients

To study serum homocysteine levels and total Antioxidant Status in vitiligo patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/01/003312
Enrollment
150
Registered
2013-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Vitiligo

Interventions

None listed

Sponsors

Employees State Insurance Corporation Post Graduate Institute of Medical Sciences Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with vitiligo attending dermatology outpatient clinic 2. Age group 18-45 years (at the time of entry into study) 3. Constant dietary habits for the past 1 year

Exclusion criteria

Exclusion criteria: 1. Cigarette smoking 2. Alcohol intake during past 3 months 3. Intake of folic acid, vitamin B6 and B12 during past 2 months 4. Intake of antioxidant supplements during past 3 months 5. Any systemic disease associated with altered serum Hcy levels. This will include known cases of cardiovascular disease, renal failure, diabetes mellitus, hypertension, hypothyroidism, hyperthyroidism & chronic liver disease and patients with any relevant findings on general and systemic examination. 6. Dermatological diseases known to affect serum Hcy levels, including psoriasis, Behcetâ??s disease, SLE. 7. Intake of any drugs known to affect Hcy levels, including methotrexate, INH, isotretinoin, cyclosporine, penicillamine, phenytoin, carbamazepine, OCPs, hydralazine, L-dopa, procarbazine, acetylcysteine, cholestyramine and cycloserine. 8. Pregnant females and females in 1-week postpartum period 9. Patients with any haematological or biochemical abnormality observed during routine laboratory investigations

Design outcomes

Primary

MeasureTime frame
To compare levels of serum homocysteine and total antioxidant status of cases to those of controlsTimepoint: 10 months

Secondary

MeasureTime frame
To correlate levels of serum homocysteine and serum antioxidant status in vitiligo patients with the activity of the diseaseTimepoint: 10 months

Countries

India

Contacts

Public ContactDR PASCHAL DSOUZA

Employees State Insurance Corporation - Post Graduate Institute of Medical Sciences & Research

dr_shikhaarora@yahoo.co.in9873668981

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026